About ACT Genomics
ACT Genomics is a Healthcare company based in Taipei (Taiwan) founded in 2014 by Joe Hsueh and Shu Jen Chen, and was acquired by Delta Electronics in June 2025. Genomics services for cancer clinical and research needs are delivered. ACT Genomics has raised $20.5 million across 4 funding rounds from investors including Prenetics, Delta Electronics and CLSA Capital Partners. ACT Genomics has completed 1 acquisition, including MC Diagnostics. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Precision Medicine.
Company details
ACT Genomics was founded in 2014 in Taipei, Taiwan, focusing on the genomics sector for cancer applications. Clinical services include next-generation sequencing panels such as ACTImmune for auto-immune diseases, ACTColon for colon cancer, ACTGastric for gastric cancer, and ACTBreast for breast cancer. Pharmacogenomic panels like ACTDrug and ACTOnco are utilized to guide therapy based on patient genotypes. Custom genomic solutions are also extended to biopharma firms and research entities.
- Headquarters Taipei, Taiwan
- Founders Joe Hsueh, Shu Jen Chen
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website actgenomics.com
- Social LinkedIn Facebook Instagram YouTube
- Acquired by Delta Electronics (Jun 2025)
- Total Equity Funding$20.5M (USD)
in 4 rounds
- InvestorsPrenetics
& 9 more
- Investments & Acquisitions
- Acquired by
Apps and channels of ACT Genomics
its YouTube channel ACT Genomics has 1.01K subscribers and 30 videos.
Videos from ACT Genomics
The most watched videos on ACT Genomics's YouTube channel, ACT Genomics (1.01K subscribers). Click a video to play it here.
More on ACT Genomics.
Funding Insights of ACT Genomics
ACT Genomics has successfully raised a total of $20.5M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20.5M
- Total Rounds 4
- First Round $8M
(Feb 2015)
- Investors Count 8
All 4 funding rounds of ACT Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2020 | Series B | – | Kyoto University Innovation Capital, Aflac Innovation Partners | – | |
| Sep 2018 | Series B | – | CLSA Capital Partners | – | |
| May 2016 | $12.5M | Series B | – | Hotung Investment Holdings, CDIB Capital | |
| Feb 2015 | $8M | Series A | – | – | – |
10 investors in total: 10 institutional.
Investors in ACT Genomics
ACT Genomics has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Prenetics, Delta Electronics and CLSA Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are made in university research startups. | 2014 | kyoto-unicap.co.jp | Kyoto, Japan | |
Investments in early to late-stage tech startups are managed. | aflacinnovationpartners.com | Minato City, Japan | ||
Venture capital firm focused on AI, IoT, cloud, agriculture, healthcare, biotech, e-commerce, and multiple sectors | 1997 | hihl.com.sg | Taipei, Taiwan | |
| pidc.com.tw | ||||
Semiconductors and diverse sectors are targeted by corporate-backed VC investments. | umccapital.com | Taipei, Taiwan | ||
PE firm investing in Asia | cdibcapital.com | Hong Kong, China | ||
REIT firm | 1986 | clsacapital.com | Hong Kong, China | |
Financial services including banking and insurance are provided to clients. | 2001 | hnfhc.com.tw | Taipei, Taiwan | |
Power management and thermal solutions are provided globally. | 1971 | deltaww.com | Taipei, Taiwan | |
Health risks are identified through online genetic and diagnostic testing. | 2009 | prenetics.com | Hong Kong, China |
Investor details for ACT Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ACT Genomics
5 people are tracked at ACT Genomics (4 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Joe Hsueh | Co-Founder & COO | Leadership |
Shu Jen Chen | Co-Founder & CSO | Leadership |
Hua Chien Chen | CSO & Co-founder | Leadership |
Victor Chan | Chief Financial Officer | Leadership |
Kuan-Wen Lin | Software Engineer | Team |
Complete people profiles for ACT Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ACT Genomics
ACT Genomics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MC Diagnostics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Molecular diagnostics automation systems | mcdiagnostics.co.uk | Llandudno, United Kingdom | 2006 | Jul 2021 | •••• |
Complete acquisition details for ACT Genomics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of ACT Genomics
6 dated milestones of ACT Genomics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded ACT Genomics is founded.
- Funding First funding round of $8.0M.
- Funding Latest funding round, Series B,.
- Acquisition Acquires MC Diagnostics.
- Exit Acquired by Prenetics.
- Exit Acquired by Delta Electronics.
Web traffic of ACT Genomics
The website of ACT Genomics (actgenomics.com) receives about 4K visits a month and ranks #3,408,080 among all websites worldwide, #4,453 in Biotechnology and Pharmaceuticals.
- Monthly visits4K
▼ 33.3% vs previous month
- Unique visitors2.5K
per month
- Global rank#3,408,080
among all websites
- Category rank#4,453
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit1.6
- Average visit13 sec
- DevicesDesktop 37% · Mobile 63%
Websites whose visitors overlap most with ACT Genomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
jwdx.com.tw | jwdx.com.tw | 100% | #3,675,955 | – | |
ansn-health.com.tw | ansn-health.com.tw | 97% | #1,860,074 | – | |
esenmedical.com | esenmedical.com | 81% | #1,622,894 | – | |
jto.org | jto.org | 62% | #339,488 | – | |
| ascopost.com | 62% | #330,660 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for ACT Genomics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Act Genomics
Complete news archive for ACT Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ACT Genomics
ACT Genomics was founded in 2014 and raised its 1st funding round 1 year after it was founded.
ACT Genomics is headquartered in Taipei, Taiwan.
ACT Genomics is a funded company, having raised a total of $20.5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $8M, raised on Feb 2015.
ACT Genomics was founded in 2014 in Taipei, Taiwan, focusing on the genomics sector for cancer applications. Clinical services include next-generation sequencing panels such as ACTImmune for auto-immune diseases, ACTColon for colon cancer, ACTGastric for gastric cancer, and ACTBreast for breast cancer. Pharmacogenomic panels like ACTDrug and ACTOnco are utilized to guide therapy based on patient genotypes. Custom genomic solutions are also extended to biopharma firms and research entities.
ACT Genomics has made 1 acquisition, including MC Diagnostics.
ACT Genomics has 10 investors. Key investors include Prenetics, Delta Electronics, CLSA Capital Partners, Hotung Investment Holdings, and Hua Nan Financial Holdings.
Yes. ACT Genomics was acquired by Delta Electronics in June 2025.